Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | PDK2 | Q15119 | 17/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29577059 | 0.95 | ALDH1A1 (0.44) | ALDH1A1MAPK1PDK2NPC1RAB9A | |
| SCHEMBL14508335 | 0.95 | ALDH1A1 (0.44) | ALDH1A1MAPK1PDK2NPC1RAB9A | |
| SCHEMBL29789018 | 0.95 | ALDH1A1 (0.44) | ALDH1A1MAPK1PDK2NPC1RAB9A | |
| SCHEMBL29789014 | 0.85 | PDK2 (0.47) | ALDH1A1MAPK1PDK2NPC1RAB9A | |
| SCHEMBL14508337 | 0.85 | PDK2 (0.47) | ALDH1A1MAPK1PDK2NPC1RAB9A | |
| SCHEMBL25818397 | 0.85 | PDK2 (0.41) | ALDH1A1MAPK1PDK2 | |
| SCHEMBL31461588 | 0.84 | ALDH1A1 (0.44) | ALDH1A1MAPK1PDK2NPC1RAB9A | |
| SCHEMBL19869566 | 0.84 | ALDH1A1 (0.44) | ALDH1A1MAPK1PDK2NPC1RAB9A | |
| SCHEMBL14508340 | 0.83 | PDK2 (0.44) | ALDH1A1MAPK1PDK2 | |
| SCHEMBL1649136 | 0.83 | PDK2 (0.47) | PDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070122652-A1 | Compound and organic electroluminescent device using same | CANON KABUSHIKI KAISHA (JP) | 2007-05-31 | — | — | US | disclosed |
| US-20070122652-A1 | Compound and organic electroluminescent device using same | CANON KABUSHIKI KAISHA (JP) | 2007-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070122652-A1 | Compound and organic electroluminescent device using same | OR10J3, LEF1, RPL19 | ALDH1A1 1832/4885MAPK1 942/4885PDK2 3230/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.